Impact of Sarcopenia on Outcome of Exercise Therapy in Older Non-Hodgkin Lymphoma Patients.
Ryuichi KasaharaTakaaki FujitaRyohei JinboJunko KubotaAya TakanoShoko TakahashiYuka OhashiKazumi JinboYuichi YamamotoTatsuyuki KaiYutaka ShigaHideo KimuraMiki FurukawaMai OwariShinichiro MorishitaPublished in: Integrative cancer therapies (2023)
Exercise therapy is effective in improving QOL in older non-Hodgkin lymphoma patients undergoing inpatient chemotherapy. However, the effect of exercise therapy and optimal exercise load may differ between non-sarcopenia and sarcopenia patients. Therefore, it is necessary to consider exercise therapy in the future, taking into account the presence or absence of sarcopenia.
Keyphrases
- physical activity
- high intensity
- end stage renal disease
- community dwelling
- skeletal muscle
- ejection fraction
- patients undergoing
- newly diagnosed
- chronic kidney disease
- resistance training
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- patient reported outcomes
- middle aged
- cell therapy
- locally advanced